Podcasts about bioreactors

Episode 102 – News From The Point Of No Return: Time Travel, Russian Nesting Dolls, and Lab-Grown Meat - Report XVIIIWelcome to the Event Horizon podcast, where we explore our world's dark and mysterious places, people, and practices. This episode is a Paranormal News show where I discuss the top three paranormal articles for the month. In this episode, we discuss:Scientists have found concrete evidence of time travel.https://www.msn.com/en-xl/news/other/scientists-have-found-concrete-evidence-of-time-travel/ar-AA1zd4CS?cvid=77FCF8948967404D809285A022FEB6F6&ocid=1PRCDEFEScientist Says He Found Evidence of Our Entire Universe is Trapped Inside a Black Hole.https://futurism.com/universe-trapped-inside-black-holeScientists create the world's largest lab-grown chicken nugget, complete with artificial veins. https://www.nbcnews.com/news/world/lab-grown-chicken-nugget-artificial-veins-rcna201837Support the ShowDid you know you can support the podcast by joining the Spreaker Supporter Club? For as little as $2.00 per month, you can help me grow the show and produce more episodes.  Go to the show page on Spreaker and click on the Supporter Club!  Supporter Club - https://www.spreaker.com/cms/shows/2860481/supporters-club/dashboard Support The Show: Make One-Time DonationCashApp - $mpeter1896PayPal - mpeter1896@gmai.comFollow Me On Social MediaCome with me and take a walk into the Event Horizon:Facebook at https://www.facebook.com/quantumAIradioTwitter at @EventHo14339589Instagram at @EventHorizon Email at eventhorizon1.618@gmail.com Please join the community and share your thoughts.Follow My Other PodcastsIf you like Event Horizon and are a political junkie, you might like my podcast, "The Mark Peterson Show." Please check it out on Spreaker https://www.spreaker.com/show/the_mark_peterson_show. I just released an episode about the death of Angela Chao, sister-in-law of Senate Minority Leader Mitch McConnell.  You might also like my new podcast, "Movie Reviews from the Edge." Check it out at https://www.spreaker.com/show/movie-reviews-from-the-edge. Check out my latest review – Picard: Season One – Luciferin Transhumanism.   Buy My New BookI have a new book!  It is called Career Coaching Xs and Os: How To Master the Game of Career Development.  Transform your career trajectory with insider knowledge and actionable advice, all packed into one game-changing guide.  Get your copy on Amazon at https://a.co/d/f7irTML Become a supporter of this podcast: https://www.spreaker.com/podcast/event-horizon--2860481/support.

In this episode of Manufacturing Hub, we welcome Amy Williams, Systems Architect at Skellig, for a deep dive into the world of life sciences manufacturing, a rarely explored but incredibly complex part of the industrial landscape.From her roots in biomolecular chemical engineering to her hands-on role in Operation Warp Speed, Amy walks us through what it's really like to build and validate manufacturing systems for pharmaceutical and biotechnology applications under FDA regulation.

The Industrial Water Solutions Conference in June is co-hosted by WateReuse and WEF. Anthony Zamora, Principal Environmental Engineer at CDM … More

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Today, we will discuss the upcoming challenge in the pharmaceutical industry of manufacturing oral GLP-1 medications, following previous issues with injectable GLP-1s. Companies like Eli Lilly and Novo Nordisk are competing for dominance in the weight loss space with these medications. Additionally, we will explore the potential impact of Trump's proposed tariffs on EU pharmaceutical companies. Humira, once a top-selling drug, is now facing declining sales as doctors switch to biosimilars and new therapies. We will also touch on the potential benefits of single-use bioreactor technology in accelerating drug manufacturing. Lastly, there are updates on various companies' financial commitments and layoffs in the industry.

Send us a textIn the fast-evolving world of biotechnology, the pursuit of efficiency and faster development has never been more critical. The computational tools and models currently being integrated into bioprocessing present a groundbreaking approach that promises radical shifts in drug development timelines and capabilities.In the second part of our conversation, Yossi Quint, founder and CEO of Ark, shows us that the horizon of bioprocessing is lined with possibilities that could revolutionize biotherapeutics accessibility, cost, and speed in pharmaceutical innovations.Here are three key takeaways you don't want to miss:De-risking with Simulation: Yossi shared how simulation models can drastically reduce risks by running many scenarios before actual implementation. This approach optimizes processes, lowers costs, and speeds up the development cycle.Transfer Learning in Bioprocessing: Discover the potential of leveraging data across different types of molecules! Although challenging, the ultimate goal is to apply data learnings from one process to others, maximizing efficiency and success rates.Patient Impact & Cost Reduction: At the heart of these innovations is the goal of quicker, more affordable drug production. By slicing down on both time and costs, computational tools not only help drugs reach the market faster but also make them more accessible to patients globally.With innovation at its core, the modern trajectory of bioprocessing is not simply about reaching scientific milestones but about profoundly transforming patient care and accessibility. This synergistic blend of technology and purpose crafts a future in which the biotechnology sector not only grows but also enriches countless lives around the globe.If you are interested in this topic, here are a few standout conversations on AI's impact on bioprocessing with some incredible experts:Episodes 131-132: Combining AI and Biomanufacturing for Sustainable, Cost-Effective Therapeutics with Reza FarahaniEpisodes 115-116: Revolutionizing Biologics Development with Hyper Throughput Screening and AI with Jeremy AgrestiEpisodes 111-112: AI Meets Biology: Why Domain Expertise Still Rules in the Age of Large Language Models with Lars BrandénEpisodes 107-108: From 1 Billion to 100: How AI is Cracking the Enzyme Discovery Code with David SchönauerEpisodes 95-96: AI in Bioprocess Development: The Game-Changer You Can't Ignore with Belma AlispahicConnect with Yossi Quint:LinkedIn: https://www.linkedin.com/in/yossi-quintArk: https://www.ark-biotech.comNext step:Wondering how to develop biomanufacturing processes with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessmentDevelop biotherapeutics better, faster, at a fraction of the cost with our 1:1 Strategy Call. Book your call at https://stan.store/SmartBiotech/p/book-a-11-call-with-me-j4vhuo6t

Send us a textThe integration of AI into drug discovery has already led to groundbreaking advancements, uncovering patterns in vast datasets that were previously invisible to human researchers. Now, AI is set to revolutionize bioprocessing as well.In this episode of the Smart Biotech Scientist Podcast, Yossi Quint, founder and CEO of Ark, and David Brühlmann explore how AI and computational tools are reshaping bioprocess development. Yossi envisions a future where 90% of bioreactor experiments could be replaced by in silico simulations, dramatically accelerating time to market and increasing throughput.Key takeaways from the conversation with Yossi Quint:AI's Role in Drug Discovery & Bioprocessing: AI is already transforming drug discovery by identifying intricate patterns across millions of data points. Now, bioprocessing is undergoing a similar revolution, as computational tools simplify and streamline complex workflows.The Power of Hybrid Models: Yossi highlights the synergy between mechanistic models and AI-driven approaches, emphasizing how AI can fill gaps where traditional models struggle—especially in understanding complex cellular behaviors.Empowering Bioprocess Teams with AI: As AI accelerates drug discovery, bioprocessing must evolve to keep pace. Yossi discusses the importance of digital transformation in ensuring bioprocess teams can meet increasing demands and drive innovation forward.With AI-driven models, hybrid simulations, and increased digitization, the bioprocessing industry stands at the cusp of a new era. The convergence of data, science, and technology promises not only greater efficiency and accuracy but also a faster path to life-saving treatments for patients in need.If you want to learn more, here are a few standout conversations on AI's impact on bioprocessing with some incredible experts:Episodes 131-132: Combining AI and Biomanufacturing for Sustainable, Cost-Effective Therapeutics with Reza FarahaniEpisodes 115-116: Revolutionizing Biologics Development with Hyper Throughput Screening and AI with Jeremy AgrestiEpisodes 111-112: AI Meets Biology: Why Domain Expertise Still Rules in the Age of Large Language Models with Lars BrandénEpisodes 107-108: From 1 Billion to 100: How AI is Cracking the Enzyme Discovery Code with David SchönauerEpisodes 95-96: AI in Bioprocess Development: The Game-Changer You Can't Ignore with Belma AlispahicConnect with Yossi Quint:LinkedIn: https://www.linkedin.com/in/yossi-quintArk: https://www.ark-biotech.comNext step:Wondering how to develop biomanufacturing processes with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessmentDevelop biotherapeutics better, faster, at a fraction of the cost with our 1:1 Strategy Call. Book your call at https://stan.store/SmartBiotech/p/book-a-11-call-with-me-j4vhuo6t

It could be argued that biology has always boiled down to chemistry, and that chemistry has always boiled down to physics. However, not many would deny that the fields of biology and chemistry are overlapping more than ever, with both leveraging computing methods, also more than ever. This conversation with Dr. Ramesh Jha, Technical Staff Member at Los Alamos National Laboratory (LANL), crosses biology, chemistry, and computing methods. The work of his biome team at LANL uses computational tools to inform the design of enzymes that are produced via PCR-based cloning and then expressed in microbes. They use fluorescent gene circuits in these microbes, along with flow cytometry, to screen these large libraries for advantageous gain-of-function variants. When they find an interesting mutation, they isolate it, sequence it, and produce and evaluate those biocatalytic enzymes for bioremediation, biomanufacturing, and other important applications. Ramesh makes this complex and interdisciplinary science approachable and gives hope to how it could help address problems of “forever chemicals” and other environmental and manufacturing challenges. Join us for this interesting and inspiring conversation.  Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.

Today we discuss a variety of composting methods and making composting the core of your homestead activities. Often people say what is the best method. Well that as always is an it depends. Bioreactor composting is my gold standard but it takes a year to make and a certain volume of materials as well. There are other methods and they all have valid results. In fact it is often a great idea to use multiple composts in making teas, extracts and slurries along with other application methods. In the end though composting can be the core of daily life on … Continue reading →

Send us a textCould Earth's gentle movements hold the key to scaling up cell therapy production? In this fascinating episode, cellular biologist and entrepreneur Olivier Detournay (CSO of Cellura) reveals how his groundbreaking bioreactor design, inspired by geophysics, is transforming difficult cell culture processes.By mimicking natural planetary motions, his team at Celura has developed a low-shear stress bioreactor that elegantly solves common scale-up challenges.Key takeaways for biotech professionals:Discover how reducing rotational speed in larger volumes (from 70 RPM at 150ml to just 4 RPM at 200L) enables seamless scale-upLearn why simplifying bioreactor design leads to better control over shear stress and mixing qualityExplore how nature-inspired solutions could make cell therapy manufacturing more accessible and cost-effectiveWhether you're working in process development or manufacturing, this episode offers invaluable insights into the future of bioprocessing.Listen now to uncover how looking to nature might help solve your toughest scale-up challenges.Connect with Olivier Detournay:LinkedIn: https://www.linkedin.com/in/olivier-detournay-5b157417Cellura: https://cellura.ioNext Steps:Wondering how to develop cell and gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessmentDevelop biologics better, faster, at a fraction of the cost with our Fractional CTO/CSO services. Curious? Learn more at https://bruehlmann-consulting.com

Send us a textWhat if the secret to growing sensitive cells lies in mimicking Earth's own movement? In this fascinating episode, cellular biologist Olivier Detournay, CSO of Cellura, reveals how studying planetary motion led to a groundbreaking bioreactor design that could transform cell therapy manufacturing.Drawing inspiration from geophysics research on magma flows, Olivier and his colleagues developed a revolutionary impeller-free bioreactor that creates gentle, uniform mixing through precise rotation and tilt angles.Key takeaways for bioprocess scientists:Learn how natural planetary movements can inspire gentler cell cultivation methodsDiscover an innovative approach to scaling up sensitive cell production without shear stressUnderstand why traditional impeller-based systems may limit the future of bioprocessingWhether you're working with stem cells, immunotherapy, or cultivated meat, this episode offers fresh perspectives on overcoming bioprocessing challenges. Join us to explore how nature-inspired solutions could make life-saving cell therapies more accessible.Connect with Olivier Detournay:LinkedIn: https://www.linkedin.com/in/olivier-detournay-5b157417Cellura: https://cellura.ioNext Steps:Wondering how to develop cell and gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessmentDevelop biologics better, faster, at a fraction of the cost with our Fractional CTO/CSO services. Curious? Learn more at https://bruehlmann-consulting.com

Today we dive into the wonder that is the Johnson-Su Bioreactor exploring the why, how, what and wheres of building this microbe and mycelium making composting system. We talk through the benefits for soil health and find the step-by-step construction amazing. Unlike the name suggests, this isn't rocket science and actually an easily built little system that will sit quietly on the plot for a year, busily making the most beautiful compost inoculant. There's little else discuss other than the weather : )

Denitrifying bioreactors are a key edge-of-field practice for removing excess nutrients from agricultural water before it enters our nation's waterways. But adoption of bioreactors is a tough sell, in part because it requires a less traditional ROI approach. Dr. Laura Christianson shares the details of how bioreactors work, what the ideal pairings are of edge-of-field practices and how they pay off in the long run – even in the less traditional senses.This episode is sponsored by Timewell.

The Daily Shower Thoughts podcast is produced by Klassic Studios. [Promo] Check out the Daily Dad Jokes podcast here: https://dailydadjokespodcast.com/ [Promo] The Daily Facts Podcast. Get smarter in less than 10 minutes a day. Pod links here Daily Facts website. [Promo] The Daily Life Pro Tips Podcast. Improve your life in less than 10 minutes a day. Pod links here Daily Life Pro Tips website. [Promo] Check out the Get Happy Headlines podcast by my friends, Stella and Mickey. It's a podcast dedicated to bringing you family friendly uplifting stories from around the world. Give it a listen, I know you will like it. Pod links here Get Happy Headlines website. Shower thoughts are sourced from reddit.com/r/showerthoughts Shower Thought credits: hacksoncode, Steinmetal4, LetMeExplainDis, MenInBlerg, Savage-Monkey2, Boatwhistle, wimpykidfan37, JonoProBono, Snoo_19146, SheriffColtPocatello, Ok-Software-1902, hearsdemons, natural1dave, OldTimeyMedicine, lionstigersbearsomar, Stock_Surfer, Tentmancer, TIFUstorytime, Sapphiregangster, , tuber_simulator, InfinityScientist, Pseudomonas_xx, Edawg661, dropkicked_eu, Terrible-Swim-6786 Podcast links: Spotify: https://open.spotify.com/show/3ZNciemLzVXc60uwnTRx2e Apple Podcasts: https://podcasts.apple.com/us/podcast/daily-shower-thoughts/id1634359309 Stitcher: https://www.stitcher.com/podcast/daily-dad-jokes/daily-shower-thoughts iHeart: https://iheart.com/podcast/99340139/ Amazon Music: https://music.amazon.com/podcasts/a5a434e9-da18-46a7-a434-0437ec49e1d2/daily-shower-thoughts Website: https://cms.megaphone.fm/channel/dailyshowerthoughts Social media links Facebook: https://www.facebook.com/DailyShowerThoughtsPodcast/ Twitter: https://twitter.com/DailyShowerPod Instagram: https://www.instagram.com/DailyShowerThoughtsPodcast/ TikTok: https://www.tiktok.com/@dailyshowerthoughtspod Learn more about your ad choices. Visit megaphone.fm/adchoices

While some of us knew a good bit about mRNA prior to 2020, we all got a crash course on mRNA technology and its prophylactic and therapeutic potential as a result of the COVID pandemic and subsequent SARS CoV-2 vaccine development. In fact, most of us have now received at least one mRNA vaccine at this point. Our guest for this episode, Dr. Christian Cobaugh, Co-founder and CEO of Vernal Biosciences, was a passionate believer in mRNA medicines well before the pandemic. Join us to hear his story and his passion for this technology. He walks us through the molecular methods by which high-purity mRNAs are now made and purified, as well as going into the lipid nanoparticle technology by which they're commonly delivered. As a contract development and manufacturing provider, we get to learn about the state of the market and what clients of their care about today. As a seasoned expert in this space, Christian talks about the future potential of mRNA technology for applications such as personalized cancer vaccines. If you enjoy hearing smart people talk about interesting topics with a passion, you won't want to miss this episode! Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Download Transcripts: Speaking of Mol Bio Podcast | Thermo Fisher Scientific - US Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology.

What does 'the body as a bioreactor' mean? In this discussion how scientists use the body's machinery to produce therapeutic proteins. Scott Ripley, General Manager of Nucleic Acids at Cytiva, explains that traditional bioprocessing uses external bioreactors, while the new approach leverages the body's natural processes. This method offers benefits like longer protein half-life and the ability to express multiple proteins simultaneously. Justin Eyquem, assistant professor at University of California San Francisco, discusses the potential of in vivo CAR T cell therapy, which could simplify manufacturing and reduce costs. Both approaches face challenges in quality assurance and regulatory approval but hold promise for personalized and more effective treatments.

Listen Now to Dr. Jonathan Trent Transcript Interestingly Dr. Trent had his start in oceanography and the study of small water-based lifeforms at UCSC back in the 1970’s as an undergraduate. Later at Scripps Institution of Oceanography and a post doc in Germany at the Max Planck Institute for Biochemistry he became one of the world’s experts in how biology was able to adapt to the most extreme conditions on Earth imaginable. He was brought back home to NASA Ames, where he, as an astrobiologist delved deeply into how such life might exist elsewhere in the solar system. NASA did an extensive interview of his career, posted here. Dr. Jonathan Trent Now, semi-retired in the Santa Cruz area, he brings home his knowledge of extreme forms of life in creating solutions to some of our biggest issues of today, namely the escalating food, water, and energy crisis. His latest project is called “UpCycle Systems,” and its goal is to create a cohesive green life support system for our growing need of Data Centers, places that are needed for  cloud computing, AI, Crypto, memory storage, etc.  In Dr. Trent’s vision, data centers will not simply use massive amounts of water and power, they will generate such resources by turning our organic waste  into clean power and water, with excess energy to share. This works through the combination of several innovative technologies, including bioreactors and fuel cells. I think you’ll enjoy hearing Dr. Trent’s story, we sure did! Enjoy.. UpCycle Data Centers that will contribute clean water and energy to the community instead of taking it.

Plastics are a modern miracle of science that have helped deliver both convenience and life-saving solutions. However, we must now grapple with the challenge of immense amounts of plastics in our waste streams and environment. How do we best deconstruct plastics to reusable or more bio-friendly molecules? This is the exact challenge being addressed by the work of Dr. Elizabeth (Izzy) Bell and her team at the National Renewable Energy Lab. Our conversation with Izzy showcases her ability to summarize complex topics very concisely and understandably, which she says is a skill that is critically important in her field because it's so interdisciplinary. Izzy summarizes the challenges they're working to address and then walks us through the stepwise processes she and her team use to conduct directed evolution studies. These studies aim to create and characterize enzymes capable of deconstructing common plastics, first at a laboratory scale, but eventually at an industrial scale. If you've ever wondered about how directed evolution studies are done, and the role that molecular biology plays with them, this conversation will be sure to clarify. In addition to the great science of this episode, Izzy also helps outline what it takes to get into and be successful in her field – a great resource for anyone aspiring to get into this area of research. We hear about how interdisciplinary the field is, but how that means it's also ripe with opportunity for those passionate about learning and making a difference. Join us for what is sure to be an informative and inspiring episode! Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Download Transcripts: Speaking of Mol Bio Podcast | Thermo Fisher Scientific - US Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology.

Could sound waves be the revolutionary key to gene therapy manufacturing? In this episode, Gabriel Dumy, CTO and Co-founder at Kolibri, reveals how acoustic waves are set to transform cell harvesting and gene transfection processes, making biomanufacturing more efficient and less damaging to cells.Kolibri is a company revolutionizing the way we grow and engineer cells at scale using acoustic waves.Key Takeaways:Real-Time Cell Harvesting: Discover how reconfigurable acoustic waves enable non-damaging, precise cell harvesting without the need for harsh chemicals.Enhanced Gene Transfection: Learn about breakthrough methods to make cell membranes more permeable, dramatically improving the efficiency of gene delivery.Scalable Bioproduction: Understand the scalable potential of acoustic waves in bioreactors, offering innovative solutions for complex tissue engineering and fragile cell growth.Join us to explore how these advancements could revolutionize the future of gene therapy and beyond!Connect with Gabriel DumyLinkedIn: https://www.linkedin.com/in/gabrieldumyKolibri: https://www.kolibrilab.comNext Step:Wondering how to develop biologics and cell & gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment

Are sound waves the key to revolutionizing gene therapy? In this groundbreaking episode, we sit down with Gabriel Dumy, CTO and Co-founder at Kolibri, a company revolutionizing the way we grow and engineer cells at scale using acoustic waves.Gabriel shares the challenges facing modern bioproduction and unveils an exciting solution that's setting the stage for the future of gene therapy.Key Takeaways:Enhanced Cell Productivity: Discover how acoustic waves minimize shear stress, significantly boosting mammalian cell productivity and density.Versatile Bioreactor Design: Learn about a cell-agnostic technology that seamlessly adapts to various cell lines, simplifying process development.Scalable Innovation: Understand the potential of this scalable tech to maintain consistent microenvironments, paving the way for large-scale gene therapy production.Tune in to find out how acoustic waves could be the breakthrough gene therapy has been waiting for!Connect with Gabriel DumyLinkedIn: https://www.linkedin.com/in/gabrieldumyKolibri: https://www.kolibrilab.comNext Step:Wondering how to develop biologics and cell & gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment

Maya Sapir-Mir is the Co-Founder & CEO of PoLoPo, a Israel-based startup pioneering a new method of molecular farming to grow egg proteins in potatoes. In this episode, we'll talk about how Polopo leverages CRISPR to express proteins within potatoes, how molecular farming works, and the end-to-end supply chain that helps it compete against traditional agriculture.

How can you create an environment suitable for shear-stress-sensitive cells that results in higher cell concentrations and superior quality? Essentially, bionic bioreactors revolutionize this process, changing the game rules with their ability to facilitate bubble-free gas exchange.Join us in this episode as we unravel the groundbreaking innovations in bioreactor technology with our guest, Patrick Bongartz, CEO of BioThrust and the visionary mind behind stress-free cell cultivation.Key Highlights:Discover how bionic bioreactors defy conventional limitations, doubling cell densities even in sensitive cultures like insect cells, promising a paradigm shift in bioproduction efficiency.Unveil the game-changing membrane stirrer technology that not only enhances oxygen transfer but also facilitates precise pH control, revolutionizing process optimization and scalability.Embrace the challenge of disrupting conservative mindsets in the biotech industry.Embark on a journey of scientific breakthroughs and entrepreneurial resilience in this episode.Connect with Patrick Bongartz:Website: https://biothrust.deLinkedin BioThrust https://www.linkedin.com/company/biothrust-deInstagram: https://www.instagram.com/biothrustPatrick's LinkedIn: https://www.linkedin.com/in/patrick-bongartz-1106/Next Step:Wondering how to develop biologics and cell & gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment

How can you provide stress-free cultivation conditions to achieve higher cell concentrations and quality? In a nutshell, bionic bioreactors and thus change bubble-free gas exchange change the game.Join us as we delve into the future of biotech with our guest, Patrick Bongartz, CEO of BioThrust and an expert in innovative bioreactor design.Key Highlights:Unveil the groundbreaking "artificial lung," a marvel of engineering that decouples mixing and gas transfer, enabling stress-free cell growth at unprecedented densities.From scaling issues to cell sensitivity, discover the hurdles that demand ingenious solutions.Explore the critical factors when handling sensitive cell types driving bioreactor evolution.Discover how bionic bioreactors are paving the way for a stress-free future in cell cultivation.Connect with Patrick Bongartz:Website: https://biothrust.deLinkedin BioThrust https://www.linkedin.com/company/biothrust-deInstagram: https://www.instagram.com/biothrustPatrick's LinkedIn: https://www.linkedin.com/in/patrick-bongartz-1106/Next Step:Wondering how to develop biologics and cell & gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment

Today we discuss a variety of composting methods. Often people say what is the best method. Well that as always is an it depends. Bioreactor composting is my gold standard but it takes a year to make and a certain … Continue reading →

CarbonShield60 Oil Infusions 15% OFFGo to >> https://www.redpillliving.com/NEMOSCoupon Code: NEMOS(Coupon code good for one time use)Another "Plandemic" is coming, with WHO in control internationally... CDC Confirms Spread Of 'Unknown' Outbreak Aboard Cruise Ship... France outlaws criticism of vaccine, 3 years or 45,000 euros for warning people. Elon's Tesla "Bioreactor" makes mRna vaccines. "Curevac" False Israel Jews bombing Lebanon to drag us into yet more war...Republicans are wholly owned by jewry.WEF elite perverts parade nearly naked children in the streets of Spain.VanMan's Miracle Tooth Powderwww.RedPillLiving.com/VanMans✅ https://NemosNewsNetwork.com/sponsorsIf you wish to support our work by donating - Bitcoin Accepted.✅ https://NemosNewsNetwork.com/Donate———————————————————————FALL ASLEEP FAST - Stay Asleep Longer... Without Negative Side Effects.✅ https://redpillliving.com/sleep———————————————————————For breaking news from one of the most over the target and censored names in the world join our 100% Free newsletter at https://NemosNewsNetwork.com/news———————————————————————Follow on Truth Socialhttps://truthsocial.com/@REALDUSTINNEMOSAlso follow us at Gabhttps://gab.com/nemosnewsnetworkJoin our Telegram chat: https://NemosNewsNetwork.com/chat———————————————————————

Can plants be more like meat, no really? In this episode, we're spotlighting Moolec Science, a trailblazer in the food industry harnessing the power of Molecular Farming technology. Not sure what that is? Great! Because neither am I. At the helm (and joining us today) is CEO and Co-Founder Gastón Paladini, who brings a wealth of experience from his 20-year tenure at Argentina's meat production heavyweight, Paladini Group. Now Moolec Science aims to disrupt the food sector by infusing plants with animal protein genes. This company is crafting a novel category between plant-based and cell-based technologies—frankly it's a wild concept I haven't heard of before until right now. Moolec Science is dedicated to creating food ingredients that merge the cost and environmental benefits of plant-based food with the taste and functionality of animal proteins. Basically, can you make soy beans taste and behave like pork? Today, Moolec Science is traded on the Nasdaq Stock Market under the ticker "MLEC". This idea is just so crazy, I had to explore it.  ➡️ https://moolecscience.com/ ➡️ https://rosspalmer.com/gaston-paladini ➡️ Follow me on Instagram: @therosspalmer ➡️ Subscribe on YouTube: @therosspalmer

Thursday's Second Hour: Dr. Michelle Soupir at Iowa State University is doing some research on bioreactors and woodchip alternatives; and she tells us more to start the hour. Ian Cox tells us about the latest happenings at the National Farm Machinery Show in Louisville, KY including the tractor pulls and has some insight on the biggest, newest, and best on display. Don Roose from U.S. Commodities closes down the show today with our update on commodity markets.

In this episode, Lourdes Gant interviewed Josephine Pace, CEO & President of Alfa Green Solutions.  Josephine answered these questions:Can you explain to our audience what makes green algae such a promising source for sustainability and environmental impact?How does your company utilize green algae to contribute to a more sustainable future, and what specific products or technologies do you offer in this regard?Where can microalgae  have the biggest impact in fighting climate change and guarantee more sustainable processes?Enjoy! Share with us your biggest takeaway :) 

Geopolitical factors, elections, and other surprises await the agricultural economy in 2024, and Italy is first country to ban cultivated meat, grown from stem cells.

Episode Description: Karl and Erum are joined by Gabe and Samet to discuss alternative proteins and the meat market. They highlight the significance of storytelling in biotech to expand the market and the role of early adopters in this process. The conversation touches on the environmental impact of animal agriculture and the advantages of alternative protein sources. The group explores how technology can revolutionize the availability of premium products in the mass market and shares insights on the initial launch strategy through partnerships and food service. They also delve into the possibilities of culturing extinct and unique animals. Karl and Erum stress the importance of networking and building connections within the synthetic biology space. Grow Everything brings to life the bioeconomy when hosts Karl Schmieder and Erum Azeez Khan share stories from the field and interview leaders and influencers in the space.  Life is a powerful force and it can be engineered. What are we creating? Learn more at ⁠www.messaginglab.com/groweverything⁠ Topics Covered: 00:00:00 - Introduction & the Future of Food 00:01:13 - Celebrating Thanksgiving & Food Innovations 00:03:08 - Guest Introduction: Gabe & Samet's Background 00:04:46 - Environmental Impact of Traditional Livestock Farming 00:07:30 - The Science Behind Cultured Meats 00:09:16 - Scaling Up Cell-Ag Technologies 00:11:03 - Consumer Perceptions and Acceptance 00:13:58 - Regulatory Landscape and Safety 00:15:45 - Comparison to Plant-based Proteins 00:18:30 - Economic Implications and Price Parity 00:20:15 - Innovations in Cellular Agriculture 00:22:59 - Strategies for a Sustainable Food Future 00:24:48 - The Role of Traditional Meat in Culture 00:26:35 - The Evolution of Meat Consumption 00:28:23 - Livestock's Contribution to Greenhouse Gases 00:30:11 - Land Use and Agriculture's Big Picture 00:31:57 - Cellular Agriculture vs. Insect Protein 00:33:42 - The Potential to Transform Livestock Farming 00:35:31 - Food Diversity and Consumer Choice 00:37:17 - FDA's Support for Cellular Agriculture 00:39:00 - Bioreactors and the Future of Food Production 00:42:37 - Consumer Interest and Storytelling Importance 00:44:26 - Comparing Biotech Examples from Other Industries 00:46:15 - Small-scale Bioreactors and Distribution Models 00:48:02 - Wrap-Up & Closing Thoughts on Cellular Agriculture Episode Links: Samet S. Yildirim, MSc, MBS on ⁠LinkedIn⁠ Gabriel Levesque-Tremblay on ⁠LinkedIn⁠ ⁠Rethink X Report on Food and Agriculture⁠ ⁠Orbillion Bio⁠ Get $200 off ⁠Synbiobeta⁠ tickets, use code: “messaginglab” Call or Text the Grow Everything Hotline:  +1 804-505-5553 Have a question or comment? Message us here: ⁠Instagram⁠ / ⁠TikTok⁠ / ⁠Twitter⁠ / ⁠LinkedIn⁠ / ⁠Youtube⁠ / ⁠GrowEverything website⁠ Email: groweverything@messaginglab.com Support here: ⁠Patreon⁠ Music by: Nihilore Production by: Amplafy Media --- Send in a voice message: https://podcasters.spotify.com/pod/show/messaginglab/message

Ever After Foods, an innovative food tech company based in Haifa, Israel, recently unveiled its groundbreaking bioreactor system designed for producing cultivated meat. In this episode of the Xtalks Food Podcast, Sydney interviews Eyal Rosenthal, CEO of Ever After Foods, to find out more about the company and the future of cultivated meat.Eyal discusses the benefits of cultivated meat, including its environmental sustainability and animal welfare, as well as its challenges, like consumer acceptance. He applauds the recent USDA approval of cultivated meat in the US and talks about what this means for the future of the industry throughout the rest of the world. Read the full article here:Ever After Foods' Revolutionary Bioreactor Platform for Cultivated Meat ProductionFor more food and beverage industry content, visit the Xtalks Vitals homepage.Follow Us on Social Media Twitter: @XtalksFood Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

Welcome to SciSection! Joining us in today's interview is our special guest Tiffany Dang! Tiffany is currently a Biomedical Engineering PhD student From the University of Calgary

https://www.barrainversa.cat/

How did this Edinburgh Professor move from studying physics to starting a Biotechnology spin-out company? In our new episode, we hear from Professor Teuta Pilizota all about how her past research experiences led her to where she is today, how her research keeps leading her to new technological developments and how this culminated in her starting a biotech spin-out company.  Many researchers spent a significant amount of time cultivating microorganisms, so they reach the desired growth phase and density. But what if that whole process could be automated, monitored and measured? This is where the OGI Bio Bioreactor comes in, to save time and allow specifications of culture conditions. Find out more about OGI Bio here: https://ogibio.co.uk/ Interview & artwork by Liz Gaberdiel, intro & editing by Ruby White.

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Will Patrick, CEO at Culture Biosciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Will, covering: How time at Google, MIT and Kendall Square led him to build disruptive tools and hardware for the bioprocessing sector Creating a cloud-based, real-time data alternative for companies wanting access to bioreactors... without the need for large-scale investment Why biotech and biopharma firms are embracing digitization, virtualization, and simulation... but less so at CDMOs Raising funds from VCs that understand the need for technological disruption How biotechs, biopharma companies, and CDMOs alike can leverage Culture's proprietary, integrated, and cloud-based single-use reactor platform How enhanced data-driven modeling and simulation can save a lot of time and costs in upstream bioprocess development going forward Will is an entrepreneurial engineer with a background in mechanical engineering, product design, and bioengineering. He develops hardware products at the interface of biology and digital fabrication. He holds 17 patents and has published 4 peer-reviewed journal articles. He currently runs Culture Biosciences, a company building and operating automated bioreactor infrastructure for the biotech industry. Will graduated from the MIT Media Lab in 2015 where he was a researcher in the Mediated Matter group. His research focuses on 3D printing fluidic systems and their applications in biotechnology and product design. Previously, he worked at Google[x] as a Rapid Evaluator where he developed and prototyped new projects for the organization. Will was a founding member of the Google[x] UAV delivery project, Project Wing, was an early team member of Project Loon, and also led the launch communications for Project Glass. Please subscribe, tell your industry colleagues, and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.

In this podcast, we talked with Dr. Ma Sha, Head of Bioprocess Applications at Eppendorf SE about advancements and challenges in cell and gene therapy production along with solutions for scale up and transition to stirred-tank bioreactor suspension culture. We began the interview by talking about the biggest advancements in cell and gene therapy, including CAR T-cell therapy development, clinical results and FDA approvals. Another area of great advancement is induced Pluripotent Stem Cell (iPSC) Culture technique. Dr. Sha explained that it used to be very difficult to culture iPSCs until it was possible to culture iPSC suspension spheres in stirred-tank bioreactors, which was a big breakthrough in the cell and gene therapy area. I followed up by asking Dr. Sha what he sees as the major challenges in the development and production of cell and gene therapies that still need to be addressed. He said that one of the major breakthroughs has been the autologous therapies that have been approved, particularly CAR T-cell therapies. However, this has also been a major challenge, because the autologous model is not cost effective. As a result, there has been a shift toward developing allogeneic therapies and building this production model will be a major challenge moving forward. Another challenge on the manufacturing side is ensuring to follow Good Manufacturing Practice (GMP), as it has been a common request from cell and gene therapy companies. Next, I asked him about the move from 2D to 3D culture and his experiences with this transition. Dr. Sha shared that several of the projects that Eppendorf bioprocess works on start as 2D culture in flasks, it is a natural place to start for most of the cell lines since they are attachment cells. They must then be converted into suspension culture to enable 3D culture, since 2D culture significantly limits the yield and productivity. He went on to say that if you look back at the evolution of antibody production, it was important to convert production to suspension cell culture and this is also necessary for the cell and gene therapy field. Moving from 2D to 3D culture and especially utilizing stirred-tank bioreactors enables much higher yields. As it stands, the yield for cellular therapy cell production is fairly low, especially compared to the industry standard of CHO cells used for antibody production, so a lot of improvement needs to happen. We then discussed stirred-tank bioreactors and their increased use in cell and gene therapy development and production. I asked Dr. Sha what are the key factors that developers should consider when choosing stirred-tank bioreactors. He explained that stirred-tank bioreactors fit the model of allogeneic production. Autologous models are not suitable for stirred-tank bioreactors. Developer companies need to keep in mind that if they want to move to stirred tank bioreactor platform, they need the production model to be allogeneic. In addition, it is important to consider the support available with respect to scaling up and leveraging supplier experience. For example, Eppendorf bioprocess over the years has produced many application notes to help customers scale their manufacturing. They have even built model production systems in Eppendorf stirred-tank bioreactors. The program called “Scale up Assist” allows customers to skip much of the difficult calculations required to achieve reproducible yields when moving from smaller to larger vessels. Eppendorf has a very long history of working in protein-based therapeutic cell culture production and about ten years ago expanded to include cell and gene therapy. I asked Dr. Sha in his experiences, what are the most important takeaways in terms of areas that still need work and advancements on the horizon. For instance, what can we learn from protein-based therapy cell culture to apply to cell and gene therapy production? He said that he thought that allogeneic production is a great lesson learn...

Making habitats from available materials will be a big part of Mars missions. One of the 2023 NIAC awards explored the possibility of growing structures on Mars with the help of fungi and bacteria. We're discussing this project with Dr Congrui Jin.

Making habitats from available materials will be a big part of Mars missions. One of the 2023 NIAC awards explored the possibility of growing structures on Mars with the help of fungi and bacteria. We're discussing this project with Dr Congrui Jin.

We need to scale. But how? The biotech space is will go through some growing pains. Find out about scalability issues like bioreactor capacity, the supply of inputs, and the lack of brains. As well as lessons we can learn from vertical farming companies that are already a step or two further down the line. Join me for a chat with Elliot Schwartz, he is the Lead Scientist for Cultivated Meat at The Good Food. If you are not familiar with precision fermentation check out t episode 1 of this season where we explain a bunch of the terms. LINKS Check out our supporter of this season ProVeg Incubator and their 12-month incubator program: https://provegincubator.com/ More info and links to resources on https://redtogreen.solutions/ Connect with Marina Schmidt https://www.linkedin.com/in/schmidt-marina/ Check out our supporter of this season, FoodLabs, and their Climate Program: https://www.foodlabs.com/ More info and links to resources on https://redtogreen.solutions/ Hashtags for this episode Bioreactor capacity Fermentor Scaling Biotechnology Scaling food technology Cultured Meat Cultivated Meat Cell-based meat Lab-grown meat Future of cultured meat Hashtags for this season Biotechnology in food Food Tech Food Technology Future of Food Food Innovation What is biotechnology food Food biotechnology examples Food biotechnology startups Biotechnology food companies Biotech food in usa Food biotechnology examples Editor's note: this episode was lengthened with a ProVeg shout out at minute 8:30

https://www.entheogenbiotech.ca/Article: https://sflcn.com/entheogen-biotech-of-canada-conducting-research-on-mushrooms-in-jamaica/  Bioreactor: https://youtu.be/gIUHQNFKu_IqNMR httpToday we welcome Anthony Bailey and Co- Founder of Entheogen Biotech to the TrueLife podcast. They have established a library with strains as strong as 4.4% tryptamine content. In establishing our library of over 100 strains of fungi we've established analytic techniques to determine tryptamine contents at home for up to 2% tryptamine and new methods using each HPLC's and Q NMR's machines. Our most unique offering is strain of mycelium that we stumbled upon in our breeding process, this particular strain produces psilocybin. We then took this strain and grew it in a bioreactor producing psilocybin in one-week versus the traditional eight-week life cycle of psilocybin.Now we embark on commercialising our findings and bring them to market their legal jurisdiction permits.

Today on Mushroom Hour we have the privilege of interviewing Professor Vera Meyer from the Technical University of Berlin. Professor Meyer's career has seen her as a visiting scientist to the Imperial College of Science, Technology and Medicine in London (2003) and to the department of Fungal Genetics and Metabolomics at Leiden University in the Netherlands (2005 - 2006). In 2008, Professor Meyer was appointed assistant professor for Molecular Microbiology and Biotechnology at Leiden University, a position she held for three years. Since 2011, she has been professor at the Institute of Biotechnology and head of its department for Applied and Molecular Microbiology at the Technical University of Berlin. Her scientific work in the field of fungal biotechnology has been published in more than 100 publications. Vera also works as a visual artist, using the pseudonym V. meer. She puts a strong emphasis on sculpting and creating objects from chance finds like forest mushrooms, decaying wood and scrap metal. Inspired by her scientific work with fungi in microbiology, she combines these materials in the sense of a found object. Through her artwork, she wants to enhance the awareness for fungi and their potential in biotechnology and for a sustainable bioeconomy in general.   TOPICS COVERED:    Childhood Fascination with the Invisible   Fungal Biotechnology   Seeing Fungi as Friends and as Foes   Importance of Multi-Disciplinary Approach    Open Science Movement   Aspergillus niger, Citric Acid and the Origins of Modern Biotechnology    Primary and Secondary MetabolismModulating Metabolic Processes of Aspergillus in Making Products   Synthetic Biology   BioReactor Cultivation & Ecology of a BioReactor   Mycelium Materials   Building a Mycelium Materials Database   Transdisciplinary Collaboration   Reconciling Biotechnology with Conservation and the Precautionary Principle   EPISODE RESOURCES:   Vera Meyer Academic Page @ TU Berlin: https://www.tu.berlin/en/vcard/vera.meyer   Vera Meyer Art (V.Meer): https://www.v-meer.de/   Vera Meyer IG: https://instagram.com/v.meer_/   Art Lab Berlin: https://artlaboratory-berlin.org/de/forschung/mind-the-fungi/   TU Berlin - Natural Building Lab: https://www.nbl.berlin/   "Beauty of the Morbid" Article: https://fungalbiolbiotech.biomedcentral.com/articles/10.1186/s40694-016-0028-4   Aspergillus niger: https://en.wikipedia.org/wiki/Aspergillus_niger   Fomes fomentarius: https://en.wikipedia.org/wiki/Fomes_fomentarius   Macrolepiota procera (AKA Parasol Mushroom): https://en.wikipedia.org/wiki/Macrolepiota_procera   

TODAY'S GUEST   Vibin Joseph is the Co-founder, Executive Director, and Chief Executive Officer at BiOZEEN, a company that's revolutionizing vaccine production and reducing the cost of vaccine manufacturing around the world. He's a technopreneur, business model enthusiast, and talent facilitator with a passion to make a better world through unleashing the potential of our times. He's an Engineer with degrees from Imperial College London, and a doctorate from Warwick University, United Kingdom.   His research interest lies in the cross-functional domains of systems design, productivity, design psychology, and moderating influencers in the pharmaceutical industry.   EPISODE SUMMARY   In this conversation we talk about: Reducing vaccine manufacturing costs, and how he went about breaking the monopoly on vaccine production, training people to produce locally using these open source methods. His motivation — how he was inspired by Ayurveda and holistic principles and holistic approaches to medicine, and how he was taught these basic principles of service from his grandparents. The history of vaccine production and its inefficiency. Why vaccines aren't a very appealing business. Bioreactors and how a more modular and adaptable approach, including self cleaning modules, could really help make the process cheaper and more efficient. How to break into a tough industry and how experience can sometimes be a baggage and prevent you from seeing the obvious. How he said no to being acquired by venture capital firms and stayed true to his purpose, which was lowering the cost of vaccines. And his spiritual perspective on leading a team, managing people, and creating value in the world.   This conversation with Vibin is one of a dozen or so weekly conversations we have lined up for you with people who are trying to make our world better. These include thinkers, designers, makers, authors, entrepreneurs, and impact investors who are working to change our world for the better. So follow this podcast on your favorite podcast app, or head over to remakepod.org to subscribe.   And now, let's jump right in with Dr. Vibin Joseph.   TIMESTAMP CHAPTERS   [5:24] Life in the Present [9:04] Early Childhood Happiness [11:32] A Journey to Biology [14:55] The Scale of the Problem [19:01] The Three Major Players [23:04] Targeting the Manufacturers [25:43] An Open Source Approach [32:30] Universal Bioreactors [36:55] Overcoming Skepticism [45:43] Finding a Purpose [52:27] A Short Sermon   EPISODE LINKS Vibin's Links

Alex sits down with Will Patrick of Culture Biosciences, the company leading the way for bioreactors in the cloud. Design, monitor, and analyze high-throughput bioreactor experiments in Culture's Cloud Lab from your laptop. Culture essentially acts as a Bioreactor in the cloud allowing companies to radically accelerate their research. We learn about the basics of the platform and the ideal applications. Learn more about Culture Biosciences at https://www.culturebiosciences.com/ --- Support this podcast: https://anchor.fm/futurefoodshow/support

Get an engineer and a chiropractor if you're going to move that bioreactor. This is Episode 95 of Engineering Word Of The Day, an informal show on favorite, fascinating, or funny words and phrases used in various engineering disciplines. Originally published October 8, 2020.

What is in the This Week in Science Podcast? This Week: Black Hole Sound, Poo Pills, Abortion, Global warming will kill all the fish, Coral Coves, Sweet CO2, What's that? A tired bird?, Bats, Vegetarian kids, Bioreactor burgers, Eye Screen, Factory Resets, Reset Diseases, And Much More… Become a Patron! Check out the full episode […] The post 4 May, 2022 – Episode 874 – May the Fourth be with us! appeared first on This Week in Science - The Kickass Science Podcast.

Wildlife Conservation Association (WCA) president Vanessa Bezy and Kelly Harris from Ridge to Reefs stopped by the Nosara Podcast studio to discuss the upcoming community event and explain more on their research to a potential solution for some of our septic systems. More on the subject of Wastewater will be covered and discussed during the upcoming community meeting on March 23th. For more details please see the poster here below.

What does “progress” in developing new kinds of environmentally friendly meats look like? What are the hidden costs of cell-based and plant-based meats? Following up on their interviews with Garrett Broad (Fordham University) and Meera Zassenhaus (New Harvest) regarding cellular agriculture, Melissa and Wythe talk with Allie about some new developments in this growing sector, and what they may mean for urban growers. The Fields team, intrigued by an article in The Counter (“Lab-grown meat is supposed to be inevitable. The science tells a different story” by Joe Fassler), debates the likely trajectories of cell-based and plant-based meats and responds to different media narratives. In doing so, we challenge the inevitability of technological solutions to social and political problems such as the unequal burdens created by climate disruption and the unequal access to futuristic post-meats.Heritage Radio Network is a listener supported nonprofit podcast network. Support Fields by becoming a member!Fields is Powered by Simplecast.

The production of meat is an inefficient process that can be substantially improved using modern biotechnology methods. On this episode, Dr. Karthik Sekar discussed his new book, After Meat.

Jeremy and Ryan discuss the function of bioreactors in the development of pharmaceuticals and vaccines. Jeremy and Ryan also would like to know what YOU would like us to discuss next. You can reach Jeremy directly at jschmerer@prescouter.com to suggest our next discussion topic within the life science arena.

Jamie sits down with Jason Ahrenholz of Prinsco and Chuck Brandel of ISG to talk about the engineering behind water quality practices. Bioreactors, Saturated Buffers and more.  Listen now to get a better understanding of what it takes to increase water quality on the farm.

In this podcast, we spoke with Dr. Stephen Fey, Chief Research Officer and Co-founder, CelVivo about the importance of 3D culture and the challenges associated with growing and maintaining culture in 3D.  We also discussed using a 3D culture bioreactor system, which employs clinostat technology to culture spheroids and organoids in a way that maintains the structure and function of in vivo cells.